Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles Publisher Pubmed



Razavi ZS1 ; Tajiknia V2 ; Majidi S3 ; Ghandali M4 ; Mirzaei HR5 ; Rahimian N6 ; Hamblin MR7, 8, 9 ; Mirzaei H10
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  2. 2. Department of Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran
  4. 4. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran
  7. 7. Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, 02114, MA, United States
  8. 8. Department of Dermatology, Harvard Medical School, Boston, 02115, MA, United States
  9. 9. Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, 2028, South Africa
  10. 10. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran

Source: Critical Reviews in Oncology/Hematology Published:2021


Abstract

Gynecologic cancers involve the female genital organs, such as the vulva, vagina, cervix, endometrium, ovaries, and fallopian tubes. The occurrence and frequency of gynecologic cancer depends on personal lifestyle, history of exposure to viruses or carcinogens, genetics, body shape, and geographical habitat. For a long time, research into the molecular biology of cancer was broadly restricted to protein-coding genes. Recently it has been realized that non-coding RNAs (ncRNA), including long noncoding RNAs (LncRNAs), microRNAs, circular RNAs and piRNAs (PIWI-interacting RNAs), can all play a role in the regulation of cellular function within gynecological cancer. It is now known that ncRNAs are able to play dual roles, i.e. can exert both oncogenic or tumor suppressive functions in gynecological cancer. Moreover, several clinical trials are underway looking at the biomarker and therapeutic roles of ncRNAs. These efforts may provide a new horizon for the diagnosis and treatment of gynecological cancer. Herein, we summarize some of the ncRNAs that have been shown to be important in gynecological cancers. © 2020 Elsevier B.V.
Other Related Docs
22. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
23. Circular Rnas (Circrnas) in Cancer Proliferation: Molecular Interactions and Possible Therapeutic Targets, Non-coding RNA Transcripts In Cancer Therapy: Pre-clinical And Clinical Implications (2023)
29. A Systematic Review of Long Non-Coding Rnas With a Potential Role in Breast Cancer, Mutation Research - Reviews in Mutation Research (2021)
35. Role of Non-Coding Rnas and Exosomal Non-Coding Rnas in Retinoblastoma Progression, Frontiers in Cell and Developmental Biology (2022)
36. Microrna and Gynecological Cancers: Focus on Mir-195, Pathology Research and Practice (2023)
37. How Micrornas Affect the Pd-L1 and Its Synthetic Pathway in Cancer, International Immunopharmacology (2020)
38. Ovarian Cancer in the World: Epidemiology and Risk Factors, International Journal of Women's Health (2019)
39. Virus, Exosome, and Microrna: New Insights Into Autophagy, Advances in Experimental Medicine and Biology (2022)
42. Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases, Pathology Research and Practice (2022)